Low-Energy Extracorporeal Shockwave Therapy as a Therapeutic Option for Patients with a Secondary Late-Stage Fibro-Lymphedema After Breast Cancer Therapy: A Pilot Study,Lymphatic Research and Biology

当前位置： X-MOL 学术 › Lymphat. Res. Biol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Low-Energy Extracorporeal Shockwave Therapy as a Therapeutic Option for Patients with a Secondary Late-Stage Fibro-Lymphedema After Breast Cancer Therapy: A Pilot Study
Lymphatic Research and Biology ( IF 1.6 ) Pub Date : 2021-04-15 , DOI: 10.1089/lrb.2020.0033
Erika Joos _{1,

2} , Ina Vultureanu ₁ , Tom Nonneman ₁ , Nele Adriaenssens ₂ , Moustapha Hamdi _{2,

3} , Assaf Zeltzer _{2,

3}

Affiliation

Background: Secondary lymphedema (LE) can occur after breast cancer (BC) therapy with axillary lymph node surgery and/or radiotherapy. Reported incidence varies around 20%. The aim of this study was to see whether low-energy extracorporeal shockwave therapy (ESWT) is a therapeutic option in end-stage secondary upper limb fibro-LE.

中文翻译：

低能量体外冲击波疗法作为乳腺癌治疗后继发性晚期纤维淋巴水肿患者的治疗选择：一项初步研究

背景：继发性淋巴水肿 (LE) 可发生在乳腺癌 (BC) 腋窝淋巴结手术和/或放疗后。报告的发病率变化约 20%。本研究的目的是了解低能量体外冲击波疗法 (ESWT) 是否是晚期继发性上肢纤维性 LE 的治疗选择。

更新日期：2021-04-26

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11